Related Experiment Videos
Structure-activity studies on narcotic antagonists. 2. N-substituted ethyl 3-(m- or p-hydroxyphenyl) nipecotates
Journal of Medicinal Chemistry
|February 1, 1981
Summary
Researchers synthesized novel nipecotate derivatives to explore their potential as narcotic antagonists. The N-methyl m-hydroxy derivative surprisingly demonstrated antagonist activity, suggesting a role for specific structural features in opioid receptor interaction.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Synthesis
Background:
- Beta-phenethylamine derivatives are crucial in understanding opioid receptor interactions.
- Investigating hydroxy-substituted moieties can reveal new therapeutic targets for pain management and addiction.
- Structure-activity relationships of nipecotate analogs are key to developing effective narcotic antagonists.
Purpose of the Study:
- To synthesize N-substituted ethyl 3-(hydroxyphenyl)nipecotates.
- To evaluate the role of meta- or para-hydroxy substituted beta-phenethylamine in narcotic antagonist action.
- To explore the analgesic and antagonist activities of novel nipecotate derivatives.
Main Methods:
- Alkylation of ethyl methoxy-phenylcyanoacetate followed by hydrogenation and cyclization.
- Multi-step synthesis involving N-benzylation, O-demethylation, N-debenzylation, and N-alkylation.
- Pharmacological evaluation using mouse tail-flick and acetic writhing assays.
Main Results:
- Several synthesized compounds exhibited analgesic activity in the acetic writhing assay.
- N-n-Propyl and N-(cyclopropylmethyl) m-hydroxy derivatives showed marginal antagonist activity.
- The N-methyl m-hydroxy derivative (11m) was identified as a significant antagonist.
Conclusions:
- The study successfully synthesized a series of N-substituted ethyl 3-(hydroxyphenyl)nipecotates.
- Specific structural features, particularly the N-methyl substitution on the m-hydroxy derivative, are critical for antagonist activity.
- These findings contribute to the development of novel narcotic antagonists by elucidating structure-activity relationships.